September 2026 – Myeloma News from the Journals Read more about September 2026 – Myeloma News from the JournalsAdd new comment
Myeloma May Be Curable for Some. Experts Are Working to Arrive at a Definition for Cure. Read more about Myeloma May Be Curable for Some. Experts Are Working to Arrive at a Definition for Cure. Add new comment
NCCN Updated Myeloma Guidelines: New Recommendations Include NDMM Treatment Updates, Changes to Treatment Strategies for RRMM, and MRD Testing Read more about NCCN Updated Myeloma Guidelines: New Recommendations Include NDMM Treatment Updates, Changes to Treatment Strategies for RRMM, and MRD Testing Add new comment
CHMP Adopts Positive Opinion for Pepaxti (melflufen); Recommends Label Expansion to Earlier Lines of Treatment for Lenalidomide-Refractory Myeloma Read more about CHMP Adopts Positive Opinion for Pepaxti (melflufen); Recommends Label Expansion to Earlier Lines of Treatment for Lenalidomide-Refractory Myeloma Add new comment
IMF Advocates Move a Step Closer to Making Oral Chemotherapy Affordable in the U.S. Read more about IMF Advocates Move a Step Closer to Making Oral Chemotherapy Affordable in the U.S. Add new comment
Twenty Years, One Mission: The NLB marks a milestone at ONS 2026 Read more about Twenty Years, One Mission: The NLB marks a milestone at ONS 2026Add new comment
Phase 2 QUINTESSENTIAL Trial Results: GPRC5D-targeted CAR T Showed Significant Overall Response Rate in Relapsed/Refractory Myeloma Read more about Phase 2 QUINTESSENTIAL Trial Results: GPRC5D-targeted CAR T Showed Significant Overall Response Rate in Relapsed/Refractory MyelomaAdd new comment
The International Myeloma Foundation Mourns the Passing of Former IMF Board Member Dr. Robert A. Kyle — The Father of Multiple Myeloma Read more about The International Myeloma Foundation Mourns the Passing of Former IMF Board Member Dr. Robert A. Kyle — The Father of Multiple MyelomaAdd new comment
